INTRODUCTION
In the classical model of the basal ganglia circuitry, two parallel and distinct neural circuits connecting the input nucleus to the output nuclei have been described (Albin et al., 1989; Gerfen and Surmeier, 2011; Kreitzer and Malenka, 2008; Valjent et al., 2009) . The direct (striatonigral) pathway is composed of GABAergic medium spiny neurons (MSNs) that predominantly express dopamine D1 receptors (D1Rs) and projects monosynaptically from the striatum to the entopenduncular nucleus (EN) and substantia nigra pars reticulata (SNr). In contrast, the indirect (striatopallidal) pathway predominantly expresses D2 receptors (D2Rs) and projects from the striatum to the external segment of the globus pallidus (GPe), which then relays to the EN and SNr. These two pathways are thought to create a dynamic balance exerting opposing but coordinated actions on the control of movement, cognition, and motivational processes (Cui et al., 2013; Durieux et al., 2009; Ferguson et al., 2011; Hikida et al., 2010; Hikosaka et al., 2000; Kravitz et al., 2010 Kravitz et al., , 2012 Lobo et al., 2010; Mink, 2003; Nambu, 2008; Tai et al., 2012) . Accordingly, an imbalance between both pathways has been postulated for several brain disorders including obsessive-compulsive disorder and Parkinson's disease (Albin et al., 1989; Maia and Frank, 2011) .
The direct and indirect pathways are often described not only as functionally opposing, but also as anatomically segregated. However, this view has been challenged by single-cell tracing studies in rats and monkeys (Fujiyama et al., 2011; Kawaguchi et al., 1990; Lé vesque and Parent, 2005; Wu et al., 2000) . In the rat, of 120 striatal projection neurons that have been individually labeled in three independent publications (Fujiyama et al., 2011; Kawaguchi et al., 1990; Wu et al., 2000) , 37% projected exclusively to the GPe (''pure'' indirect pathway), whereas only 3% projected only to the SNr or EN (''pure'' direct pathway). Sixty percent of labeled neurons projected to the SNr/EN and possessed collateral terminal fields in the GPe. Because these GPe collaterals may have the ability to bridge the direct and the indirect pathways, we refer to them here as ''bridging'' collaterals. Regulating the extent of bridging collaterals could be a mechanism by which the direct pathway modulates the indirect pathway, thereby affecting the behavioral balance maintained in concert by both pathways.
Neuronal activity represents an important developmental mechanism for regulating axonal projections and establishing proper connectivity between different brain structures (Catalano and Shatz, 1998; De Marco García et al., 2011; Hua et al., 2005) . To determine whether similar mechanisms also occur in the basal ganglia circuitry of the adult animal, we took advantage of bacterial artificial chromosome (BAC) transgenic mice that express GFP under the control of the Drd1a or the Drd2 promoter (Drd1a-GFP and Drd2-GFP mice; Gong et al., 2003) . These mice label the direct and the indirect pathways, respectively, and can be used as tracing agents to visualize the axonal projections of both pathways (Valjent et al., 2009) .
Using a combination of transgenic mice and viral gene transfer strategies, we found that the density of bridging collaterals that connect the direct with the indirect pathway is regulated by neuronal excitability in the adult brain. Specifically, we found that increasing excitability of the indirect pathway is sufficient to induce the growth of bridging collaterals. Chronic upregulation of D2Rs (D2R-OE mice), which increases excitability of the indirect pathway (Cazorla et al., 2012) , similarly leads to a higher density of bridging collaterals, a phenotype that is reversed after viral-mediated decrease in excitability of D2R-OE MSNs. In contrast, genetic D2R downregulation (Drd2 À/À ) or chronic treatment with the D2R blocker haloperidol decreases the density of bridging collaterals. Increased bridging collaterals are associated with enhanced inhibition of pallidal neurons in vivo and disrupted motor activity after optogenetic stimulation of the direct pathway. Strikingly, both the behavioral and anatomical changes are reversed by chronic treatment with haloperidol. These data show structural plasticity in the adult basal ganglia that is regulated by chronic changes in the dopamine system and is sensitive to antipsychotic medication. These findings may have important implications for schizophrenia, in which D2R function is chronically increased in the striatum and for which D2R blockade with antipsychotic medication is still the most effective treatment (Howes et al., 2012) .
RESULTS

Striatopallidal MSN Excitability Regulates the Extent of Striatonigral Bridging Collaterals
In analogy to what has been observed during development, we reasoned that manipulating MSN excitability could lead to axonal remodeling of the striatal output pathways in adulthood (De Marco García et al., 2011; Hua et al., 2005) . To investigate this hypothesis in the adult animal, we injected the dorsal striatum with an adeno-associated virus (AAV) expressing the transdominant negative Kir2.1 AAA potassium channel (AAV-Kir2.1 AAA ) using Drd1a-GFP and Drd2-GFP BAC transgenic mice to label, respectively, the direct and indirect pathways (Gong et al., 2003; Valjent et al., 2009; Figures 1A-1C) . We previously showed that this strategy efficiently increases MSN excitability by downregulating endogenous inward rectifying potassium (Kir) channel function (Cazorla et al., 2012) . Quantification of Drd1a-and Drd2-GFP-positive terminal fields in AAV-Kir2.1 AAA mice revealed that increasing MSN excitability did not affect the growth of the classical striatonigral and striatopallidal terminal fields (i.e., Drd1a-GFP-positive terminals in SNr and Drd2-GFP-positive terminals in GPe, respectively) but specifically promoted the growth of striatonigral bridging collaterals in the GPe ( Figures 1B  and 1C ). The overall density of the presynaptic terminal marker synaptophysin was increased in the GPe of AAV-Kir2.1 AAA mice and colocalized with Drd1a-GFP, confirming that Drd1a-GFP-labeled terminals found in the GPe correspond to presynaptic terminals and not to fibers of passage (Figures S1A and S1B available online). Neuronal populations in the GPe have been divided into parvalbumin-positive (PV-positive) and PVnegative cells (Mallet et al., 2012) . Drd1a-GFP-labeled terminals in the GPe of both controls and AAV-Kir2.1 AAA mice were found to contact both of these subpopulations ( Figure S1C ). We then investigated whether the growth of bridging collaterals is regulated by neuronal excitability of the direct pathway (Drd1a-MSN) and/or by excitability of the indirect pathway (Drd2-MSN). AAVs expressing DIO-Kir2.1 AAA for which expression is dependent on Cre recombinase (CRE) were injected in the dorsal striatum of Drd1a-GFP;Drd2-CRE and Drd1a-GFP;Drd1a-CRE mice. This strategy allowed the quantification of Drd1a-GFP-labeled terminals after increasing MSN excitability selectively in the direct or indirect pathway ( Figures 1D-1G ). Strikingly, expression of Kir2.1 AAA in the direct pathway (Drd1a-CRE mice) had only a marginal effect on GPe collaterals, and instead led to an increase in terminal density in the SNr ( Figure 1E ). In contrast, expression of Kir2.1 AAA in the indirect pathway (Drd2-CRE mice) increased terminal fields of the direct pathway in the GPe ( Figure 1G ). These findings show that neuronal excitability of the indirect pathway is sufficient to promote the growth of GPe direct pathway bridging collaterals. Interestingly, we observed that the increase in bridging collaterals was mainly restricted to the vicinity of Kir2.1 AAA -infected striatopallidal terminals (see ''global'' versus ''local'' effect in Figure 1G) , in line with the topographical organization of striatopallidal connections (Alexander et al., 1986) .
D2 Receptors Control the Growth of Bridging Collaterals via Their Regulation of MSN Excitability
What could be a physiological mechanism regulating excitability of the indirect pathway? Indirect pathway MSNs express D2Rs and are more excitable than direct pathway MSNs that express D1R (Gertler et al., 2008) . Moreover, chronic upregulation of D2R in the striatum increases MSN excitability through the downregulation of Kir channels (Cazorla et al., 2012) , while chronic blockade of D2R using raclopride decreases excitability of the indirect pathway (Chan et al., 2012) . Based on these findings, we hypothesized that chronic changes in D2R function could regulate the extent of bridging collaterals via changes in excitability of the indirect pathway. To test this idea, mice overexpressing striatal D2Rs (D2R-OE mice; Kellendonk et al., 2006) and Drd2 knockout mice were crossed with BAC transgenic Drd1a-GFP and Drd2-GFP mice (Figure 2) . Similar to what we observed in Kir2.1 AAA mice, D2R-OE;Drd1a-GFP mice showed a dramatic 1.75-fold increase in GFP-positive terminal density in the GPe without affecting the SNr (Figure 2A ). The density of synaptophysin-positive terminals was increased in the GPe and colocalized with GFP-labeled terminals, indicating that the increase in GPe presynaptic terminals arises from MSNs of the direct pathway ( Figures S2A and S2B ). In addition, the distribution of terminals contacting PV-positive and PV-negative neurons was not changed in D2R-OE mice ( Figure S2C ). The increase in GPe terminal fields was specific for the direct pathway as GFP-labeled terminals emerging from the indirect pathway were not altered in D2R-OE;Drd2-GFP mice ( Figure 2B ). Analysis of the medial to lateral extent of bridging collaterals revealed that the highest effect size is observed in the medial part of the GPe despite an equal distribution of transgene expression in D2R-OE mice ( Figure S2D ). Associative corticostriatal loops therefore might be more affected by the increase in bridging collaterals than sensorimotor loops. To visualize individual collaterals in the GPe further, low titer viruses (1.8 3 10 8 particles) were injected into the striatum to infect only a sparse number of neurons. We used AAV-DIO-Channelrhodopsin2 (ChR2) fused to enhanced yellow fluorescent protein (eYFP) as a tracer in combination with Drd1a-CRE mice to restrict the expression of ChR2-eYFP to the direct pathway. D2R-OE mice show an increase in the arborization of individual collaterals ( Figure S2E ). Quantification revealed that the number of higher order branches was increased in D2R-OE mice, whereas the number of primary branches emerging from passing axons was unaltered (Figure S2F) . Conversely, in D2R heterozygous (Drd2 +/À ;Drd1a-GFP) and homozygous (Drd2 À/À ;Drd1a-GFP) knockout mice, we found a gene-dose-dependent decrease in GFP-positive terminal fields in the GPe ( Figure 2C ). GPe terminal fields from the indirect pathway were not altered in D2R-OE and Figure S1 . knockdown mice ( Figure 2D ). Remarkably, restoring Kir function in D2R-OE mice by injecting D2R-OE;Drd1a-GFP mice with an AAV expressing wild-type Kir2.1 (AAV-Kir2.1 WT )
reversed the morphological phenotype ( Figure 2E ), confirming that D2Rs regulate the extent of bridging collaterals via its effect on neuronal excitability.
Bridging Collaterals Are Dynamically Regulated in the Adult Brain and Are Sensitive to Chronic Administration of Haloperidol Because this reversal demonstrates structural plasticity in the adult brain, we questioned whether dynamic changes in D2R expression could affect the bridging collaterals in adulthood. In D2R-OE mice, D2R overexpression can be switched off during adulthood with doxycycline (Kellendonk et al., 2006) . Adult D2R-OE;Drd1a-GFP mice were fed doxycycline-supplemented food for 3, 7, 14, and 60 days to turn transgenic D2R expression off, and the density of GPe Drd1a-GFP-labeled terminal fields was measured ( Figure 3A ). We found that the increased GPe collateral terminal fields progressively reversed to almost control levels within 2 weeks of doxycycline treatment ( Figures 3A, 3B , S3A, and S3B). Most importantly, switching off expression in the adult for 2 weeks followed by reinitiation of D2R overexpression (2 month doxycycline withdrawal) led to regrowth of axonal terminal fields to nearly original levels, showing a high degree of structural plasticity of bridging collaterals in adulthood that is sensitive to D2R levels. Because the density of bridging collaterals can be modulated in the adult by manipulating D2R expression, we asked whether the bridging collaterals are also sensitive to pharmacological manipulation of D2R function using chronic treatment of haloperidol, a D2R blocker that is commonly used as antipsychotic medication in humans. After 2 weeks of haloperidol treatment (1 mg/kg/day), bridging collaterals were decreased in both D2R-OE and wild-type mice without affecting the classical direct and indirect pathway terminals within the SNr and GPe, respectively ( Figure 3C ). The reduction in the density of collaterals was of similar magnitude in D2R-OE mice treated for 2 weeks with either haloperidol or doxycycline (haloperidol, À72.3%; doxycycline, À75.6%; Figures 3B and 3C ). To use a different quantitative method independent of the GFP transgene, we performed western blots using the presynaptic markers synaptophysin and synaptosomal-associated protein 25. Protein levels were increased in the GPe but not the striatum . Data are presented as mean ± SEM (n = 4-6 mice/group). Insets, 403 magnification, darkfield (A) and brightfield (C). (E) Increased bridging terminal density is restored in D2R-OE mice after striatal expression of AAV-Kir2.1 WT -ires-HRGFP. *p < 0.05, ***p < 0.005, compared to Ctl+AAV-ctl; ##p < 0.01, ###p < 0.005, compared to D2R-OE+AAV-ctl. Data are presented as mean ± SEM (n = 4-6 mice/group). Scale bars, 1 mm. See also Figure S2 .
of D2R-OE mice ( Figures S3C and S3D ). These increases were reversed after switching off the transgene using doxycycline ( Figures S3C and S3D ).
Increased Bridging Collaterals Are Associated with Increased Inhibition of GPe Cells after Optogenetic Stimulation of the Direct Pathway In Vivo
Since MSNs are GABAergic, we investigated whether the direct pathway-like the indirect pathway-has the ability to inhibit GPe neurons via its bridging collaterals. Using optogenetics in anesthetized mice, we stimulated the direct and indirect pathways selectively while recording from GPe neurons. Drd1a-CRE and Drd2-CRE mice injected with AAV-DIO-ChR2 into the dorsal striatum ( Figure 4A ) were implanted into the injection site with an optic fiber connected to a laser source while a recording electrode was lowered into the GPe ( Figure 4B ). As expected, laser stimulation of indirect pathway MSNs (Drd2-CRE mice) led to massive inhibition of the majority of GPe cells, whereas control mice not injected with AAV-DIO-ChR2 (''No ChR2'') remained unaffected by laser stimulation ( Figure 4C ). Laser stimulation of direct pathway striatal neurons (Drd1a-CRE mice) also led to an inhibition of basal firing rate of GPe cells, which was smaller than in Drd2-CRE mice but enlarged in Drd1a-CRE;D2R-OE mice ( Figure 4C ). Because the basal firing rate of GPe neurons is about 10 Hz, we used 100 ms bins to sample the responses. The latency of inhibition was comparable among Drd1a-CRE;control, Drd1a-CRE;D2R-OE, and Drd2-CRE mice, occurring for most activity recorded within the first 100 ms ( Figure 4D ). Because the indirect pathway (Drd2-CRE mice) is an established monosynaptic pathway, the data are consistent with a functional monosynaptic inhibition emerging also from the direct pathway. Figure 4E shows a comparison of relative spike numbers among the four groups.
To quantify the degree of inhibition, we used Z score analysis ( Figure 4F ). The three experimental groups, Drd1a-CRE, Drd1a-CRE;D2R-OE, and Drd2-CRE mice, differed significantly from the non-ChR2 transfected control group (one-way ANOVA [F(3,242) = 14.494; p < 0.001], Scheffe corrected post hoc comparisons, p < 0.05) and from each other [F(2,212) = 6.950, p < 0.01] ( Figure 4F ). Pair-wise comparisons of the Z scores revealed that optical stimulation of striatopallidal neurons in Drd2-CRE mice was more effective than stimulation of striatonigral neurons at inhibiting GPe neurons in Drd1a-CRE mice. Similarly, Drd1a-CRE;D2R-OE mice (M = À3.7118, SEM = 0.49125) showed significantly more inhibition than Drd1a-CRE mice (M = À1.9028, SEM = 0.29643), while not differing from Drd2-CRE mice (M = À3.6796, SEM = 0.39120).
Based on Z score analysis, we found the proportion of inhibited GPe neurons to be 68.4% in Drd2-CRE, 39.0% in Drd1a-CRE, and 62.9% in Drd1a-CRE;D2R-OE mice ( Figures 4G and 4H) . A Pearson chi-square test revealed a higher proportion of inhibited cells in Drd1a-CRE;D2R-OE mice than in Drd1a-CRE mice (p < 0.01), with no significant differences compared to Drd2-CRE mice. Inhibited units showed 55%, 71%, and 90% reduction in activity compared to their prestimulation values in Drd1a-CRE, Drd1a-CRE;D2R-OE, and Drd2-CRE mice, respectively (Figure 4I) . The degree of inhibition differed between all three groups [F(2,116) = 38.086, p < 0.01]. Basal firing rates were not affected by the D2R transgene, but Drd2-CRE mice showed lower basal firing rates than control Drd1a-CRE ''No ChR2'' mice (Drd1a-CRE ''No ChR2'' mice: 13.3 ± 1.8 Hz; Drd1a-CRE + ChR2: 10.8 ± 1.0 Hz; Drd1a-CRE;D2R-OE + ChR2: 13.1 ± 1.1 Hz; (A) Transgenic D2R mRNA expression (upper row; in situ hybridization; scale bar, 500 mm) is switched off in adult D2R-OE mice by doxycycline application (Dox on). Expression is re-established after removal of doxycycline (Dox on then off). Increased striatonigral GPe collaterals (bottom row; Drd1a-GFP immunostaining; scale bar, 100 mm) are reversed to normal after switching transgene expression off (Dox on). Collaterals grow back after re-expressing the transgene (Dox on then off). (B) Kinetics of collaterals retraction in the GPe of D2R-OE mice treated with doxycycline for increasing time periods and regrowth after re-expressing the transgene for 60 days (14 on + 60 off). Values are normalized to control mice and are presented as mean ± SEM (n = 5-6 mice/group). (C) Reduction of striatonigral but not striatopallidal terminals in the GPe of control and D2R-OE mice treated for 14 days with haloperidol (1 mg/kg/day). *p < 0.05, **p < 0.01, ***p < 0.005, compared to control; ##p < 0.01, compared to D2R-OE. Data are presented as mean ± SEM (n = 8-9 mice/group). See also Figure S3 .
Drd2-CRE + ChR2: 7.5 ± 0.6 Hz; one-way ANOVA, [F(3,242) = 7.560, p < 0.01], post hoc Scheffe corrected p < 0.05 for comparison between Drd1a-CRE ''No ChR2'' and Drd2-CRE mice). This in vivo analysis of GPe firing is consistent with fast inhibition by direct pathway collaterals. It further suggests that increased density of bridging collaterals in D2R-OE mice strengthens inhibitory modulation of the GPe, a major node of the indirect pathway.
Changes in Bridging Collaterals Are Associated with Disrupted Motor Behavior after Stimulation of the Direct Pathway Could increased inhibition in the GPe affect the behavioral balance of the direct and indirect pathways? Recently, Kravitz et al. (2010) have shown that in vivo stimulation of the direct pathway increases locomotion while stimulation of the indirect pathway inhibits locomotion. Nevertheless, under nonstimulated conditions, initiation of movements requires the concurrent and coordinated activation of both pathways (Cui et al., 2013) . Here, we hypothesize that the increased inhibition of the GPe associated with the increase in bridging collaterals should affect behavioral activation after direct pathway stimulation and thereby change the coordinated balance of the pathways.
We first analyzed locomotor activity in mice coinjected with AAV-DIO-ChR2 and the nonconditional AAV-Kir2.1
AAA that leads to an increase in bridging collaterals without affecting the classical terminal fields ( Figure 1B ). Coinjection with a control virus led to increased locomotor activity after direct pathway stimulation ( Figures 5A and 5B) and decreased locomotor activity after stimulation of the indirect pathway ( Figures 5C and D) , as previously described (Kravitz et al., 2010) . This effect was specific to laser stimulation as the general motor activity of the mice was not affected during habituation ( Figures S4A-S4F ) or when the laser was switched off. Mice injected with DIO-ChR2 that do not Figures 5A and 5B), while inhibition of locomotor activity after stimulating the indirect pathway remained unchanged ( Figures 5C and 5D ).
Because D2 receptor upregulation increases bridging collaterals, an effect that is rescued by haloperidol, we also assessed direct-pathway-dependent locomotor activation in D2R-OE mice treated with chronic haloperidol. Drd1a-CRE mice crossed with D2R-OE mice were injected with AAV-DIO-ChR2 into the dorsal striatum and were then treated with either saline or haloperidol (1 mg/kg/day) for 2 weeks before analysis of motor behaviors (Figures 6 and S5 ). As observed in the Kir2.1 AAA experiment, direct pathway stimulation increased locomotor activity in Drd1a-CRE;control mice but decreased locomotor activity in Drd1a-CRE;D2R-OE mice (p = 0.001; laser/control versus laser/D2R-OE). The effect size was larger in D2R-OE mice than in AAV-Kir2.1 AAA -injected mice, probably due to the fact that the expression area of Kir2.1 AAA is restricted to the injection sites, whereas D2R are upregulated in the entire striatum of D2R-OE mice (Kellendonk et al., 2006) . Basal (unstimulated) locomotor activity was not altered in D2R-OE mice (Figures 6 and S5 ). We also tested the effects of chronic haloperidol treatment (2 weeks, 1 mg/kg/day) on direct-pathway-dependent locomotion. Laser stimulation of the direct pathway in Drd1a-CRE;control mice treated with haloperidol efficiently induced locomotion to levels of saline-treated mice despite decreased baseline activity (p = 0.001; pre-/postcontrol + saline versus pre-/ postcontrol + haloperidol; Figures 6 and S5) . Remarkably, (B) Summary of locomotor activity during a 30 s session measured in (A). ###p < 0.0001, repeated two-way ANOVA; ***p < 0.0001 compared to laser. Data are presented as mean ± SEM (n = 6-8 mice/ group). A significant interaction between D2R manipulation (D2R-OE and/or haloperidol) and laser illumination was observed (p < 0.0001). Chronic haloperidol has no effect on behavioral inhibition after indirect pathway activation (see Figure S5 ). chronic treatment with haloperidol reversed the locomotor phenotype observed in D2R-OE mice to the level of control mice. This reversal was also observed using a same-subject longitudinal design in a subgroup of mice that was tested before and after chronic haloperidol treatment ( Figure S5E ). Chronic haloperidol treatment had no effect on motor activity after stimulation of the indirect pathway in Drd2-CRE mice (Figures S5F and S5G ), despite the fact that the indirect pathway predominantly expresses D2Rs.
DISCUSSION
Neuronal activity has been found to be important during development for regulating axonal projections and establishing proper connectivity between different brain regions (Catalano and Shatz, 1998; De Marco García et al., 2011; Hua et al., 2005) . De Marco García et al. (2011) have recently shown that, during embryonic development, decreasing excitability via overexpression of Kir channels impairs proper axonal path finding of cortical interneurons. In the adult animal, decreasing excitability of olfactory sensory neurons via Kir overexpression also disrupts the formation of a proper olfactory map (Yu et al., 2004) . However, olfactory sensory neurons regenerate throughout adulthood and the olfactory system is known for its high degree of plasticity. Here, using Kir-expressing viruses, we show that manipulating excitability in the adult brain alters axonal terminal fields in the basal ganglia, a structure that is a priori not known for its structural plasticity. In contrast to what has been observed during development and the olfactory system, structural plasticity of bridging collaterals is not cell autonomous since collaterals of direct pathway grow after increasing excitability of indirect pathway neurons.
It is currently unclear why this anatomical reorganization is specific for the bridging collaterals of the direct pathway and does not affect the classical terminal fields of the direct and indirect pathways. We believe that this is related to the noncell-autonomous nature of the mechanism. Altered activity of the indirect pathway may lead to the release of growth factors within the GPe (by indirect pathway terminals or GPe target neurons) that are specifically recognized by direct pathway bridging collaterals. This is particularly exemplified by the locally restricted growth of bridging collaterals that remain in the vicinity of AAV-DIO-Kir2.1 AAA -infected striatopallidal projections.
What are the potential physiological mechanisms involved in this anatomical rearrangement? Since neuronal excitability of indirect pathway neurons seemed to be critical for the growth of direct pathway collaterals, we focused on regulatory mechanisms specific to this neuronal population. Striatopallidal neurons of the indirect pathway predominantly express D2 receptors. Chronic D2R overexpression increases excitability of the indirect pathway via downregulation of Kir channels, whereas chronic blockade of D2Rs with raclopride decreases striatopallidal excitability (Cazorla et al., 2012; Chan et al., 2012) . Changes in excitability of indirect pathway neurons through regulation of Kir potassium conductances or by chronic blockade of dopamine D2 receptors revealed plasticity in bridging collaterals into the GPe. Surprisingly, this anatomical rearrangement is bidirectionally regulated by D2Rs and is extremely plastic in adult animals. For instance, increased collaterals in D2R-OE mice disappear 2 weeks after restoring D2R expression to normal levels and then reappear after reinstating D2R overexpression (by switching the transgene off and then on). Importantly, pharmacological blockade of D2R function in the adult animal with chronic administration of haloperidol also led to a decrease in direct pathway collaterals without affecting the classical terminal fields of the direct and indirect pathways. This demonstrates that chronic administration of antipsychotic medication in adulthood leads to specific changes in neuronal connectivity in the adult basal ganglia circuitry.
GABAergic neurons of the indirect pathway are known to inhibit the GPe. In line with this, we found that optogenetic activation of the indirect pathway in vivo inhibited GPe activity. Surprisingly, we found that optogenetic activation of the direct pathway also inhibited GPe neurons in vivo with the same latency as activation of the indirect pathway. This inhibition was significantly increased in D2R-OE mice that possess excess bridging collaterals, suggesting that increased bridging collaterals could be responsible for the increase in inhibition via monosynaptic inhibition. The direct and the indirect pathways have classically been thought about as two functionally opposing pathways (Albin et al., 1989; Maia and Frank, 2011) . This holds true for motor behaviors and is consistent with optogenetic studies showing that direct pathway stimulation produces locomotor activation whereas indirect pathway stimulation inhibits locomotion (Kravitz et al., 2010) . The opposing function of both pathways is also discussed in the context of motivation and cognition, with the direct pathway being involved in learning from positive outcomes and the indirect pathway in learning from negative outcomes (Durieux et al., 2009; Ferguson et al., 2011; Frank et al., 2004; Graybiel, 2000; Hikida et al., 2010; Kravitz et al., 2010 Kravitz et al., , 2012 Tai et al., 2012) . Other models propose coordinated activation of both pathways that could be simultaneous or sequential in nature (Hikosaka et al., 2000; Mink, 2003; Nambu, 2008) or could rather involve the direct and the hyperdirect pathway (Leblois et al., 2006) . Coordinated activation of direct and indirect pathways in motor control is supported by a recent study using in vivo calcium imaging showing that both pathways are coactivated during locomotor initiation (Cui et al., 2013) . The density of bridging collaterals could be the mean to regulate the coordinated actions of both pathways.
The fact that the observed anatomical changes are selective for the bridging collaterals of the direct pathway and that the behavioral activation of the direct-but not indirect-pathway is disrupted implies a functional role of these collaterals in regulating striatal-dependent behaviors. Our in vivo recordings suggest that bridging collaterals may form a functional bridge between the direct and the indirect pathways, hence acting as a concurrent ''brake'' when the ''accelerator'' (direct) pathway is activated (Graybiel, 2000) . To test this idea, we used the open field experiment designed by Kravitz et al. (2010) as a readout for direct and indirect pathway strength. In both mouse models with increased bridging collaterals (AAV-Kir2.1 AAA and D2R-OE mice), behavioral activation of the direct pathway was disrupted, in line with the observation of the selective anatomical changes in the direct pathway. In fact, direct pathway stimulation leads to decreased locomotor activity in Kir2.1 AAA and D2R-OE mice, while wild-type mice show increased locomotor activity. Strikingly, this decrease is reversed by chronic pharmacological blockade of D2Rs, emphasizing the importance of D2R function in this plasticity.
The decrease in locomotor activity after direct pathway activation in Kir2.1 AAA and D2R-OE mice may be explained by the increased inhibition of GPe neurons, therefore reinforcing the ''brake'' action of the indirect pathway. In contrast, retracting collaterals should weaken the indirect pathway. Following this idea, we expected that haloperidol-treated mice that have less bridging collaterals would show facilitated locomotor activity after direct pathway stimulation due to decreased opposition by collateral input to the GPe. We did not observe this, possibly due to a ceiling effect of optogenetic stimulation. Although the behavioral data are consistent with increased inhibition by GPe collaterals, it is possible that other mechanisms are contributing to the behavioral inhibition after direct pathway stimulation. For example, increased D2R expression and increased striatal excitability may have led to reversible changes within the striatum that do not allow optimal activation of the direct pathway, thereby impairing the efficacy of the striatonigral synapse. Moreover, functional connectivity within the basal can also be due to plasticity in striatal input. In line with this hypothesis, altered activity within the striatum during postnatal development has been shown to regulate the strength of excitatory input to the striatum (Kozorovitskiy et al., 2012) .
The direct and indirect pathways are important not only for regulating motor activity but also for motivational and cognitive behaviors (Maia and Frank, 2011) . Regulating the extent of bridging collaterals therefore might be important not only for refining locomotion but also for regulating cognitive and motivational behaviors. For instance, D2R-OE mice show deficits in motivation and cognition that resemble negative and cognitive symptoms observed in patients with schizophrenia (Bach et al., 2008; Drew et al., 2007; Kellendonk et al., 2006; Simpson et al., 2012; Ward et al., 2012) . Both the deficits in motivation and the anatomical changes are reversed after reversing D2R levels to normality in adulthood. It is therefore possible that the changes in bridging collaterals are responsible for the motivational deficits. In contrast, the cognitive deficits persist after reversing D2R overexpression, suggesting that the anatomical changes are not sufficient to explain the cognitive deficits (Bach et al., 2008; Kellendonk et al., 2006) . To address causality between bridging collaterals and motivation, the collaterals will have to be manipulated directly without affecting neuronal excitability or D2R function. Anatomical changes in the bridging collaterals may also contribute to basal ganglia disorders such as Parkinson's disease, in which an imbalance of the direct and indirect pathways has been postulated (Albin et al., 1989; Maia and Frank, 2011) . In this context, it would be interesting to examine bridging collaterals in mouse models of Parkinson's disease.
Finally, there is evidence for increased D2R stimulation in the striatum (associative caudate) of patients with schizophrenia (Howes et al., 2012; Kegeles et al., 2010; Simpson et al., 2010) . D2R-OE mice were originally designed to model this aspect of the disorder (Kellendonk et al., 2006) . We therefore hypothesize that increased bridging terminals and the resulting changes in the balance of the direct and indirect pathways might also exist in patients with schizophrenia. Advanced brain-imaging technologies capable of identifying changes at the level of terminal fields might be used in the future to test this hypothesis. In this context, it is interesting that chronic treatment with haloperidol, a widely used antipsychotic medication to treat patients with schizophrenia, reverses both the anatomical alteration and the disrupted behavioral consequence of direct pathway stimulation in D2R-OE mice. The longitudinal study following the same animals before and after treatment strongly suggests that haloperidol corrects the direct-pathway-dependent behavioral deficits by reversing the increase in collaterals. Because all effective pharmacotherapies for positive symptoms of schizophrenia target D2Rs, we propose here that these medications possibly attenuate positive symptoms by correcting an anatomical imbalance between the direct and indirect pathways.
EXPERIMENTAL PROCEDURES Animals
All animal protocols used in the present study were approved by the New York State Psychiatric Institute and Columbia University Institutional Animal Care and Use Committees. The generation of the D2R-OE mice has been described previously (Kellendonk et al., 2006) . TetO-D2R mice have been backcrossed for over 15 generations onto the C57BL/6J background and CaMKIIa-tTA mice backcrossed for over 20 generations onto 129SveVTac. To generate D2R-OE mice, tetO-D2R/C57BL6 mice were crossed with CaMKIIa-tTA/ 129SveV mice. Only double transgenic mice express transgenic D2Rs (D2R-OE mice). Littermates carrying a single transgene (tetO or tTA) or no transgene were used as controls. Drd2-GFP (S118Gsat/Mmnc), Drd1a-GFP (X60Gsat/ Mmmh), Drd2-CRE (ER44Gsat/Mmcd), and Drd1a-CRE (FK150Gsat/Mmcd) mice were purchased from MMRRC, and Drd2 À/À (B6.129S2-Drd2tm1Low/J) were purchased from Jackson Laboratory. These strains were crossed to obtain D2R-OE; Drd2 À/À ;Drd1a-GFP, Drd2
Drd1a-GFP, Drd2
+/À ;Drd2-GFP, Drd1a-GFP;Drd1a-CRE, and Drd1a-GFP;Drd2-CRE mice. All controls were littermates. Only adult mice were used in this study. For unknown reasons, no Drd2 À/À ;Drd2-GFP mice could be obtained. Mice were housed under a 12 hr light/dark cycle in a temperature-controlled environment with food and water available ad libitum.
Drug Treatments
Expression of transgenic D2R in D2R-OE mice was switched off by feeding the mice with regular chows supplemented with doxycycline (40 mg/kg diet). Reexpression of transgenic D2R was allowed by replacing doxycycline-supplemented food with regular pellets for 60 days. Re-expression of transgenic D2R was assessed by in situ hybridization (Kellendonk et al., 2006) .
Chronic treatment with haloperidol (1 mg/kg/day) was performed using miniosmotic pumps (Alzet, model 2002) to provide a steady delivery rate of 0.5 ml/hr for 14 days. Haloperidol was dissolved in 8.5% lactic acid (six parts) then neutralized with 1N NaOH (four parts). Minipumps filled with either lactic acid/NaOH or haloperidol were implanted subcutaneously in the interscapular region under isoflurane anesthesia.
Histology and Quantification of Terminal Field Density
Terminal quantification was estimated by immunohistochemistry against aequorea GFP expressed in Drd1a-GFP and Drd2-GFP mice. Mice were anaesthetized with a mixture of ketamine and xylazine (100 mg/kg and 10 mg/kg) injected intraperitoneally (i.p.) and transcardiacally perfused with first PBS and then 4% paraformaldehyde. Following perfusion, brains were postfixed in 4% paraformaldehyde for 16 hr, extensively washed, and sliced into 50 mm sagittal sections on a vibratome (Leica Microsystems). Immunostaining was performed on free-floating sections from either right or left hemisphere. Every fourth section covering GPe and SNr in their entirety (approximately six slices per mouse) was stained using a rabbit polyclonal antibody against aequorea GFP (1:2,000; Molecular Probes). The signal was revealed using a biotinylated anti-rabbit (1:1,000; Jackson ImmunoResearch) Vectastain ABC Elite kit (Vector Labs) and 3,3 0 diaminobenzidine (Vector Labs). Contrast was intensified using 0.025% nickel cobalt and 0.02% nickel ammonium sulfate. Sections were dehydrated, cleared, and mounted on slides with Permount (Fisher Scientific). Brightfield and darkfield photomicrographs were taken using an AxioImager 2 microscope (Zeiss) connected to an AxioCam video camera and to Neurolucida v.10 (MBF Bioscience). Terminal density was evaluated using GFP staining. Quantification was performed using ImageJ v.1.46r by experimenters blind of genotypes/injections using two random counting frames per structure and per slice. Optical density in the striatum was not affected by genotype or Kir channel expression and was used as an internal control, so all values are in percentage of striatal optical density. All effects were cross-examined and validated using dark field microscopy (Zeiss) at a higher magnification (103 and 403) and in some occurrences using synaptophysin quantification (mouse monoclonal anti-synaptophysin, 1:100; Abcam). Note that antibodies directed against aequorea GFP expressed in Drd1a-GFP and Drd2-GFP mice do not recognize renilla GFP expressed by AAVires-HRGFP.
Immunofluorescence was performed on free-floating, 50-mm-thick sections using rabbit anti-aequorea GFP (1:2,000; Molecular Probes), chicken antiaequorea GFP (1:1,000; Abcam), rabbit anti-DsRed (1:1,000; Clontech), rabbit anti-CRE (1:1,000; Kellendonk et al., 1999) , mouse anti-PV (1:2,000; Sigma), and the appropriate fluorescent-labeled secondary antibodies. Sections were mounted on slides with VectaShield+DAPI (Vector Labs). Images were acquired using an AxioImager fluorescence microscope (Zeiss) or an LSM 510 META confocal system (Zeiss) mounted on an inverted Axiovert 200M microscope (Zeiss) at the Herbert Irving Comprehensive Cancer Center confocal facility (Columbia University).
Virus Constructs AAV2/1-cmv-Kir2.1 AAA -ires-HRGFP and AAV2/1-cmv-Kir2.1 WT -ires-HRGFP viruses were generated by inserting mouse Kir2.1 AAA or Kir2.1 WT sequences, respectively, into the multiple cloning site of the pAAV-ires-HRGFP vector (Agilent Technologies) as described in Cazorla et al. (2012) . AAV2/1-syn-DIO-Kir2.1 AAA -ires-mCherry was generated by replacing the ef1a promoter and ChR2-eYFP sequence with the synapsin promoter and Kir2.1 AAA -iresmCherry sequence into the pAAV-ef1a-DIO-hChR2(H134R)-eYFP vector (kind gift of Karl Deisseroth).
PBS/5% glycerol; 0.44 ml) in the mediodorsal striatum (AP +1.0, ML ±1.4, DV À3.1) of Drd1a-CRE;control and Drd1a-CRE;D2R-OE mice. Expression of the virus was allowed for a period of 4 weeks. For optical fibers implantation, the injection glass pipette was removed and fiberoptic implants were placed in the dorsomedial striatum (AP +0.8, ML ±1.8, DV À3.2). The implant was secured to the skull using dental cement (Dentsply). After wound closure, mice received analgesics and antibiotics and were returned to their home cage for >4 weeks. Virus spreading and gene expression were assessed after each experiment. Variability was very low and no mice were removed from any experiment.
In Vivo Optical Stimulation
Optical fibers were constructed in house by interfacing a 200 mm, 0.37-numerical-aperture optical fiber (Fiber Instrument Sales) with a 1.25 mm stick zirconium ferrule. The fiber extended 4 mm beyond the end of the ferrule. Fibers were attached with epoxy resin into the ferrules, then cut with a diamond pen and polished. All fibers were calibrated to have >80% efficiency of light transmission. Fiberoptic patch cords with a 200 mm core diameter were also constructed in house using an FC/PC connectorization kit (Thor Labs).
In Vivo Recording
Anesthetized mice (chloral hydrate) were implanted with an optic fiber for light stimulation into the site of ChR2 injection in the dorsomedial striatum (AP +1.5, ML ±1.1, DV À3.3). A glass electrode (impedance 12-14 MU) filled with 2 M NaCl was lowered into the GPe (AP À0.1, ML ±1.8, DV À2.5). The electrode was lowered using a hydraulic microdrive to detect spontaneously active pallidal neurons. From this starting point, the GPe was sampled in four locations 0.15 mm apart and arranged in a 2 3 2 spaced grid moving in a clockwise direction. The starting locations were counterbalanced across animals and groups. Pallidal neurons were identified using a combination of sterotaxic position and narrow action potential width (<1 ms). After 2-3 min of stable recording, optical stimulation (473 nm; 2 mW) was applied for 5 s as recording continued. Neuronal activity was amplified and filtered (1,0003 gain, 100-10K Hz band pass) and fed to an audio monitor and to a computer interface with custom-designed acquisition and analysis software (Neuroscope).
Traces from continuous recordings were analyzed offline, first by applying a window discriminator to identify spikes, then from the spike table to calculate firing rates. Peri-stimulus time histograms were obtained by sampling spike frequency with 100 ms bins 5 s before, during, and after laser illumination.
Relative spike frequency is expressed as a function of baseline firing obtained during the 5 s preceding laser illumination. Average firing rate during the 5 s of laser stimulation was expressed as a percent change and a Z score of the prestimulation firing rate distribution, which was determined from five 1 s bins pseudorandomly sampled from the 60 s prior to stimulation. Cells with Z scores more negative than À2 (cutoff for a one-tailed p < 0.05) were defined as being significantly inhibited by striatal efferent stimulation. Proportion of cells with significant changes in spike firing following laser stimulation and amplitude of inhibition, calculated as (1 post-/prefiring rate) 3 100, were also analyzed and compared.
Data Analysis and Statistics
Data were analyzed using Prism 5 (GraphPad) and Statview. Terminal field density was analyzed using unpaired Student's t test when only two conditions were compared within a group (GPe or SNr) or one-way ANOVA followed by a Bonferroni post hoc test when more than two conditions were compared within a group. In vivo recordings were analyzed using a paired t test to compare pre-to postfiring rate distribution, a Pearson's chi-square test to compare the proportion of inhibited units across different groups, and oneway ANOVA followed by post hoc comparisons for the degree of inhibition (expressed as both Z score and percentage change from prestimulation spike firing). Motor activity was analyzed using two-way ANOVA with repeated measures. The p values of repeated ANOVAs are given for each type of activity. Virus expression (AAV-ctl or AAV-Kir2.1 
